David Cummings is a seasoned venture partner at Molten Ventures since March 2020 and has held the position of partner at DFJ Esprit / Draper Esprit / Encore Ventures since January 2012. As an investor director, David operates with several companies including Paragraf® and FocalPoint, both since 2021, as well as Hadean and Endomag, where Endomag was acquired by Hologic for $310 million in July 2024. Additionally, David has been a partner at Trinamo since 2007 and an angel investor with Cambridge Angels since June 2005. Prior affiliations include partner at Cambridge Accelerator Partners from 2003 to 2012 and senior director at KPMG Corporate Finance from 2004 to 2011. David holds an M.B.A. from London Business School and an MA in Natural Sciences from the University of Cambridge.
This person is not in any teams
This person is not in any offices